# Sleep Number Corp: Form 10-Q for the period ended Mar 29, 2025

- Company: [Sleep Number Corp](/companies/snbrq.md) (CIK 827187)
- Form: 10-Q
- Filed: 2025-05-06
- Accepted by EDGAR: May 6, 2025, 16:13 ET
- Period: 2025-03-29
- Accession: 0000827187-25-000058
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/827187/000082718725000058/snbr-20250329.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/827187/000082718725000058/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-03-29.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2024-12-29 to 2025-03-29 | $393.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2024-12-29 to 2025-03-29 | $152.7m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2024-12-29 to 2025-03-29 | $240.5m | us-gaap:GrossProfit |
| Research and development | 3 months, 2024-12-29 to 2025-03-29 | $10.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2024-12-29 to 2025-03-29 | $1.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2024-12-29 to 2025-03-29 | $11.1m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months, 2024-12-29 to 2025-03-29 | −$585.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2024-12-29 to 2025-03-29 | −$8.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2024-12-29 to 2025-03-29 | −$0.38 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2024-12-29 to 2025-03-29 | −$0.38 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2024-12-29 to 2025-03-29 | 22,706,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2024-12-29 to 2025-03-29 | −$2.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2024-12-29 to 2025-03-29 | $4.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months, 2024-12-29 to 2025-03-29 | $563.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2025-03-29 | $1.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-03-29 | $175.4m | us-gaap:AssetsCurrent |
| Total assets | at 2025-03-29 | $836.8m | us-gaap:Assets |
| Current liabilities | at 2025-03-29 | $904.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-03-29 | $1.29bn | us-gaap:Liabilities |
| Current portion of debt | at 2025-03-29 | $557.7m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2025-03-29 | −$456.8m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2025-03-29 | 22,660,000 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 32,386 characters.

### OPERATIONS

Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is intended to provide

a reader of the Company’s condensed consolidated financial statements with a narrative from the perspective of

management on its financial condition, results of operations, liquidity and certain other factors that may affect the

Company’s future results. MD&A is presented in seven sections:

- Forward-Looking Statements and Risk Factors
- Business Overview
- Results of Operations
- Liquidity and Capital Resources
- Non-GAAP Data Reconciliations
- Critical Accounting Policies

### Forward-looking Statements and Risk Factors

### The discussion in this Quarterly Report on Form 10-Q contains certain forward-looking statements that relate to

### future plans, events, financial results or performance. You can identify forward-looking statements by those that

### are not historical in nature, particularly those that use terminology such as “may,” “will,” “should,” “could,”

### “expect,” “anticipate,” “believe,” “estimate,” “plan,” “project,” “predict,” “intend,” “potential,” “continue” or

### the negative of these or similar terms. These statements are subject to certain risks and uncertainties that could

### cause actual results to differ materially from the Company’s historical experience and its present expectations or

### projections. These risks and uncertainties include, among others:

- Changes in economic conditions and consumer sentiment and related impacts on discretionary consumer spending;
- Interest rates remain elevated, and may further increase and impact the cost of servicing the Company’s

indebtedness;

- Access to alternative financing options may depend on factors beyond the Company’s control or require the

Company to accept unfavorable terms;

- Availability of attractive and cost-effective consumer credit options;
- Ability to achieve cost savings, efficiencies and other benefits from its business restructuring actions and to avoid

adverse effects;

- Effectiveness and efficiency of the Company’s marketing strategy and promotions;
- Ability to execute Sleep Number’s Total Retail distribution strategy;
- Ability to compete effectively;
- Ability to achieve and maintain high levels of product and service quality;
- Ability to improve and expand the product line and execute new product introductions;
- Ability to protect the Company’s technology, trademarks and brand, and the adequacy of its intellectual property

rights;

- Dependence on, and ability to maintain working relationships with key suppliers and third parties, including some

that are the only source of supply or services currently used by the Company;

- Fluctuations in commodity costs or third-party delivery or logistics costs and other inflationary pressures;
- Risks inherent in global-sourcing activities, including tariffs, foreign regulation, geo-political turmoil, war, pandemics,

labor challenges, foreign currency fluctuations, inflation, climate or other disasters and resulting supply shortages,

and production and delivery delays and disruptions;

- Operating with minimal levels of inventory, which may leave the Company vulnerable to supply shortages;
- Risks of disruption in the operation of any of the Company’s facilities and operations, including manufacturing,

assembly, distribution, logistics, field services, home delivery, headquarters, product development, retail or customer

service operations;

- Ability to effectively complete potential future acquisitions and business combinations;
- Sleep Number’s ability, and the ability of its suppliers and vendors, to attract, retain and motivate qualified and

effective personnel;

### 16 \| 1Q 2025 FORM 10-Q SLEEP NUMBER CORPORATION

- Ability to comply with existing and changing government regulations and laws, and to commercialize new products

and innovations that meet those existing and changing government regulations and laws;

- Ability to identify and withstand cyber threats that could compromise the security of the Company’s systems or those

of third parties upon which it relies and could result in a data breach or business disruption;

- Risks associated with advancements in or adoption of artificial intelligence technologies;
- Adequacy of the Company’s and third-party information systems, and costs and disruptions related to upgrading or

maintaining these systems;

- Volatility of Sleep Number stock, its removal from various stock indices and the potential negative effects of

shareholder activism or of changes in coverage by securities analysts;

- Unfavorable tax treatment;
- Environmental, social and governance risks, including increasing scrutiny and evolving regulatory and stakeholder

expectations; and

- Ability to adapt to climate change and readiness for legal or regulatory responses thereto.

### Additional information concerning these, and other risks and uncertainties is contained under the caption “Risk

### Factors” in Part I, Item 1A. in the Company’s Annual Report on Form 10-K and in Part II. Item 1A. in subsequent

### Quarterly Reports on Form 10-Q.

The Company has no obligation to publicly update or revise any of the forward-looking statements contained in this

Quarterly Report on Form 10-Q.

### Business Overview

Sleep Number is a wellness company and market leader in the design, manufacturing, marketing and distribution of

highly innovative sleep solutions. The Company’s purpose is to improve the health and wellbeing of society through

higher quality sleep; to date, it has improved the lives of nearly 16 million people. Sleep Number’s Smart Sleepers

benefit from individualized sleep experiences, night after night, and are experiencing the physical, mental and emotional

benefits of life-changing sleep.

Sleep Number’s life-changing, differentiated smart beds combine physical and digital innovations, integrating

unparalleled physical comfort with a highly advanced sleep wellness platform. The smart beds offer the Company’s

signature firmness adjustability, enabling each sleeper adjustable comfort. Embedded digital sensors learn the sleep

needs of each individual; “sense and do” technology uses the sensed data to automatically adjust the smart bed to keep

the sleeper comfortable throughout the night. Active temperature balancing technology supports the ideal climate for

each sleeper and solves a prevalent sleep challenge. Additionally, the smart beds are an exceptional value, with

personalized sleep insights delivered daily, new features regularly added to all smart beds through over-the-air updates

and prices to meet most budgets. Sleep Number® smart beds provide unmatched features, benefits and comfort that

can lead to improved sleep health and wellness for both sleepers.

The Company’s advantaged business model is supported by its consumer innovation strategy: an individualized, digital

sleep wellness platform, a network of millions of highly engaged Smart Sleepers who are loyal brand advocates, a

vertically integrated operating model and a culture of individuality, with an ambitious vision to become one of the

world’s most beloved brands.

The Company’s 3,600 mission-driven team members are dedicated to the Company’s mission of improving lives by

individualizing sleep experiences. They passionately innovate to drive value creation, including our exclusive direct-to-

consumer selling in nearly 640 stores and online, which meets customers whenever and wherever they choose to provide

an exceptional experience and a lifelong relationship. Additionally, the Company partners with world-leading institutions

to bring the power of 33 billion hours of longitudinal sleep data to sleep science and research.

The bedding industry has been in a sector level recession for three years with mattress industry unit volumes returning to

an estimated 24 million units in 2024, the lowest level since 2015. Consumer sentiment remains well below historical

averages, and high interest rates are putting ongoing pressure on the housing market. Consumers continue to scrutinize

spending, with inflation and other factors weighing on their purchasing power. Since initiating the Company’s operating

model transformation in the fourth quarter of 2023, the Company has executed structural changes to reduce fixed

expenses, while prioritizing improving margins and generating cash to create greater financial resilience across market

cycles.

### 17 \| 1Q 2025 FORM 10-Q SLEEP NUMBER CORPORATION

### Results of Operations

#### Quarterly and Year-to-Date Results

Quarterly and year-to-date operating results may fluctuate significantly as a result of a variety of factors, including

increases or decreases in sales, timing, amount and effectiveness of advertising expenditures, changes in sales return

rates or warranty experience, timing of investments in growth initiatives and infrastructure, timing of store openings/

closings and related expenses, changes in net sales resulting from changes in the Company’s store base, timing of new

product introductions and related expenses, timing of promotional offerings, competitive factors, changes in commodity

costs, disruptions in global supplies or third-party service providers, seasonality of retail and bedding industry sales,

consumer sentiment and general economic conditions. The extent to which these external factors will impact the

Company’s business and its consolidated financial results will depend on future developments, which are highly

uncertain and cannot be predicted. Therefore, the historical results of operations may not be indicative of the results that

may be achieved for any future period.

#### Highlights

Financial highlights for the three months ended March 29, 2025 were as follows:

- Net sales for the three months ended March 29, 2025 of $393 million decreased 16% from $470 million for the same

period one year ago driven by lower volume and reduced store count.

- The net sales change resulted from a 15% Total Retail comparable sales decrease. For additional details, see the

components of total net sales change on page 19.

- Average sales per store (sales for stores open at least one year, Total Retail, including online, phone and chat) on a

trailing twelve-month basis for the period ended March 29, 2025 totaled $2.5 million, compared with $2.8 million for

the same period one year ago.

- Operating income for the three months ended March 29, 2025 was $2 million, compared with $6 million for the

same period one year ago. The $4 million decrease in operating income was driven by the lower net sales; partially

offset by a $32 million reduction in operating expenses and a 2.5 ppt. increase in the gross profit rate.

- Adjusted EBITDA for the three months ended March 29, 2025 was $22 million, compared to $37 million for the same

period one year ago as ongoing gross margin improvements and cost reduction actions partially offset the year-

over-year net sales decline.

- Gross profit rate of 61.2% was 2.5 ppt. higher than the prior-year period. The increase was primarily due to year-

over-year product cost reductions through value engineering and ongoing supplier negotiations and favorable

product mix. See the gross profit discussion on page 20 for additional details.

- The $32 million year-over-year reduction in the Company’s operating expenses was due to lower sales and

marketing expenses and restructuring costs.

- Net loss for the three months ended March 29, 2025 was $9 million, compared with $7 million for the same period

one year ago. Net loss per diluted share was $0.38, compared with $0.33 for the same period one year ago.

- The Company’s adjusted return on invested capital (Adjusted ROIC) was 7.2% on a trailing twelve-month basis for

the period ended March 29, 2025, compared with 4.5% for the comparable period one year ago.

- The Company used $3 million in cash from operating activities for the three months ended March 29, 2025,

compared with providing $34 million for the same period one year ago.

- Free cash flow used $7 million for the three months ended March 29, 2025, compared with providing $24 million for

the same period one year ago.

- As of March 29, 2025, the Company had $558 million of borrowings under its revolving credit facility.

### 18 \| 1Q 2025 FORM 10-Q SLEEP NUMBER CORPORATION

The following table sets forth the Company’s results of operations expressed as dollars and percentages of net sales.

Figures are in millions, except percentages and per share amounts. Amounts may not add due to rounding differences.

|  | Three Months Ended March 29, 2025 |  | March 30, 2024 |  |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $393.3 | 100.0% | $470.4 | 100.0% |
| Cost of sales | 152.7 | 38.8% | 194.3 | 41.3% |
| Gross profit | 240.5 | 61.2% | 276.2 | 58.7% |
| Operating expenses: |  |  |  |  |
| Sales and marketing | 189.1 | 48.1% | 208.5 | 44.3% |
| General and administrative | 38.6 | 9.8% | 39.1 | 8.3% |
| Research and development | 10.9 | 2.8% | 12.4 | 2.6% |
| Restructuring costs | 0.1 | —% | 10.6 | 2.3% |
| Total operating expenses | 238.7 | 60.7% | 270.6 | 57.5% |
| Operating income | 1.9 | 0.5% | 5.5 | 1.2% |
| Interest expense, net | 11.1 | 2.8% | 12.3 | 2.6% |
| Loss before income taxes | (9.2) | (2.3%) | (6.8) | (1.4%) |
| Income tax (benefit) expense | (0.6) | (0.1%) | 0.7 | 0.2% |
| Net loss | $(8.6) | (2.2%) | $(7.5) | (1.6%) |
| Net loss per share: |  |  |  |  |
| Basic | $(0.38) |  | $(0.33) |  |
| Diluted | $(0.38) |  | $(0.33) |  |
| Weighted-average number of common shares: |  |  |  |  |
| Basic | 22.7 |  | 22.5 |  |
| Diluted | 22.7 |  | 22.5 |  |

The percentage of total net sales, by dollar volume, was as follows:

|  | Three Months Ended March 29, 2025 | March 30, 2024 |
| --- | ---: | ---: |
| Retail stores | 87.6% | 88.2% |
| Online, phone, chat and other | 12.4% | 11.8% |
| Total Company | 100.0% | 100.0% |

### 19 \| 1Q 2025 FORM 10-Q SLEEP NUMBER CORPORATION

The components of total net sales change, including comparable net sales changes, were as follows:

| Sales change rates: | Three Months Ended March 29, 2025 | March 30, 2024 |
| --- | ---: | ---: |
| Retail comparable-store sales (1) | (15%) | (10%) |
| Online, phone and chat | (12%) | (19%) |
| Total Retail comparable sales change (1) | (15%) | (11%) |
| Net opened/closed stores and other | (1%) | 0% |
| Total Company | (16%) | (11%) |

(1) Stores are included in the comparable-store calculations in the 13th full month of operations. Stores that have been remodeled or repositioned

within the same shopping center remain in the comparable-store base.

Other sales metrics were as follows:

|  | Three Months Ended March 29, 2025 | March 30, 2024 |
| --- | ---: | ---: |
| Average sales per store (1) (in thousands) | $2,495 | $2,786 |
| Average sales per square foot (1) | $807 | $903 |
| Stores \> $2 million in net sales (2) | 51% | 63% |
| Stores \> $3 million in net sales (2) | 15% | 23% |
| Average revenue per smart bed unit – Total Retail (3) | $5,992 | $5,765 |

(1) Trailing-twelve months Total Retail comparable sales per store open at least one year.

(2) Trailing-twelve months for stores open at least one year (excludes Online, Phone and Chat sales).

(3) Represents Total Retail net sales divided by Total Retail smart bed units.

The number of retail stores operating was as follows:

|  | Three Months Ended March 29, 2025 | March 30, 2024 |
| --- | ---: | ---: |
| Beginning of period | 640 | 672 |
| Opened | 2 | 6 |
| Closed | (5) | (17) |
| End of period | 637 | 661 |

### 20 \| 1Q 2025 FORM 10-Q SLEEP NUMBER CORPORATION

### Comparison of Three Months Ended March 29, 2025 with Three Months Ended March 30, 2024

#### Net sales

Net sales for the three months ended March 29, 2025 of $393 million decreased 16% from $470 million for the same

period one year ago driven by lower volume and reduced store count. The net sales change consisted primarily of a

15% Total Retail comparable sales decrease.

The $77 million net sales decrease compared with the same period one year ago was comprised of the following: (i) a

$60 million decrease in Retail comparable net sales; (ii) a $7 million decrease from online, phone and chat; and (iii) a $10

million decrease from net store closings and other. Total Retail smart bed unit sales decreased 19% compared with the

prior year. Total Retail average revenue per smart bed unit increased by 4% to $5,992, compared with $5,765 in the

prior-year period.

#### Gross profit

Gross profit of $241 million for the three months ended March 29, 2025 decreased by $36 million, or 13%, compared

with $276 million for the same period one year ago. The gross profit rate increased to 61.2% of net sales for the three

months ended March 29, 2025, compared with 58.7% for the prior-year comparable period.

The current-year gross profit rate increase of 2.5 ppt. was mainly due to: (i) year-over-year product cost reductions

through value engineering and ongoing supplier negotiations, increased the rate by 250 ppt; (ii) a favorable product mix,

increased the rate by 30 ppt; (iii) and efficiency gains in our home delivery and logistics operations, increased the rate by

30 ppt; partially offset by (iv) lower delivered smart bed volume deleveraged the rate by 90 ppt. In addition, the gross

profit rate may fluctuate from quarter to quarter due to a variety of other factors, including changes in warranty

expenses, return and exchange costs, manufacturing and supply chain operations and performance-based incentive

compensation.

#### Sales and marketing expenses

Sales and marketing expenses for the three months ended March 29, 2025 were $189 million, or 48.1% of net sales,

compared with $209 million, or 44.3% of net sales, for the same period one year ago. The current-year sales and

marketing expenses rate increase of 3.8 ppt. was primarily due to the deleveraging impact of an 16% net sales decline,

partially offset by a 9% decrease in sales and marketing expenses including a 9% lower media spend.

#### General and administrative expenses

General and administrative (G&A) expenses totaled $39 million for both the three months ended March 29, 2025 and

March 30, 2024 which was 9.8% and 8.3% of net sales, respectively. The changes in G&A expenses consisted mainly of:

(i) a $1.4 million year-over-year decrease in company-wide, performance-based incentive compensation and (ii) a $0.9

million decrease in depreciation and amortization; offset by (iii) a $1.6 million increase in professional and consulting fees

primarily related to proxy contest and CEO search costs that occurred during the three months ended March 29, 2025;

and (iv) a $0.3 million increase in employee compensation. The G&A expenses rate increased by 1.5 ppt. in the current-

year period, compared with the same period one year ago due to the items discussed above offset by the deleveraging

impact of lower net sales.

#### Research and development expenses

Research and development (R&D) expenses totaled $11 million for the three months ended March 29, 2025, compared

with $12 million with the same period one year ago. The changes in R&D expenses were primarily due to lower

headcount and outside services. Moving forward, the Company’s innovation agenda will focus on maintaining and

improving the Company’s core technologies and introducing additional advancements, while driving costs out of the

product.

#### Interest expense, net

Interest expense, net totaled $11 million for the three months ended March 29, 2025, compared with $12 million for the

same period one year ago. The $1 million decrease was mainly driven by a lower weighted-average interest rate

compared with the same period one year ago.

### 21 \| 1Q 2025 FORM 10-Q SLEEP NUMBER CORPORATION

#### Restructuring Costs

Restructuring costs for the three months ended March 29, 2025 were $0.1 million, compared with $11 million for the

same period one year ago. In the fourth quarter of 2023, the Company initiated business restructuring activities. Charges

incurred related to this initiative were comprised of contract termination costs, severance and employee-related benefits,

professional fees and other, and asset impairment charges and are included in the restructuring costs line in the

Company’s condensed consolidated statement of operations. The Company expects an additional $10 million to

$15 million of restructuring costs to be incurred through the remainder of 2025, primarily due to severance and

employee-related benefits, contract termination costs, and asset impairment charges. See Note 12, *Restructuring Costs,*

of the Notes to Condensed Consolidated Financial Statements included in Part I, Item 1, *Financial Information*, of this

Quarterly Report on Form 10-Q for further information on restructuring costs.

#### Income tax (benefit) expense

Income tax benefit totaled $0.6 million for the three months ended March 29, 2025, compared with income tax expense

of $0.7 million for the same period one year ago. The change in income tax expense was primarily due to the change in

discrete tax expense, driven by stock-based compensation tax shortfalls, which were $1.0 million for the three months

ended March 29, 2025, compared to $2.2 million for the same period one year ago.

### Liquidity and Capital Resources

Managing liquidity and capital resources is an important part of the Company’s commitment to deliver superior

shareholder value over time.

The Company’s primary sources of liquidity are cash flows provided by operating activities and cash available under its

$675 million revolving credit facility, as amended. As of March 29, 2025, the Company does not have any off-balance

sheet financing other than its $7 million in outstanding letters of credit. The cash generated from ongoing operations

and cash available under the revolving credit facility are expected to be adequate to maintain operations, and fund

anticipated expansion, strategic initiatives and contractual obligations such as lease payments and capital commitments

for new retail stores for the foreseeable future.

Cash and cash equivalents totaled $1.7 million and $2.0 million at March 29, 2025 and December 28, 2024, respectively.

Significant changes in cash and cash equivalents during the three months ended March 29, 2025 primarily consisted of

$3 million of cash used in operating activities, $5 million of cash used to purchase property and equipment, a $9 million

increase in short-term borrowings, offset by $2 million used for debt issuance costs.

The following table summarizes cash flows (in millions). Amounts may not add due to rounding differences:

| Total cash (used in) provided by: | Three Months Ended March 29, 2025 | March 30, 2024 |
| --- | ---: | ---: |
| Operating activities | $(2.6) | $33.7 |
| Investing activities | (4.6) | (12.3) |
| Financing activities | 7.0 | (22.0) |
| Net decrease in cash and cash equivalents | $(0.3) | $(0.5) |

Net cash used in operating activities for the three months ended March 29, 2025 was $3 million, compared with net cash

provided by operating activities of $34 million for the three months ended March 30, 2024. Significant components of

the year-over-year change in cash provided by operating activities included: (i) a $15 million fluctuation in inventory as

last year benefited from reduction in inventory levels driven by operational improvements; (ii) a $10 million fluctuation in

the amount of compensation and benefits accrued and timing of the related payments resulting from year-over-year

changes in Company-wide performance-based incentive compensation; and (iii) a $8 million fluctuation in customer

prepayments; (iv) partially offset by a $12 million fluctuation in accounts payable.

Net cash used in investing activities for the three months ended March 29, 2025 was $5 million, compared with

$12 million for the three months ended March 30, 2024. Cash used to purchase property and equipment was $5 million

### 22 \| 1Q 2025 FORM 10-Q SLEEP NUMBER CORPORATION

for the three months ended March 29, 2025, compared with $9 million for the same period one year ago. In addition, the

Company issued $3 million of notes receivable during the three months ended March 30, 2024.

Net cash provided by financing activities was $7 million for the three months ended March 29, 2025, compared with net

cash used in financing activities of $22 million for the same period one year ago. Short-term borrowings increased by

$9 million during the current-year period due to an $11 million increase in borrowings under the revolving credit facility

to $558 million and a $2 million decrease in book overdrafts, which are included in the net change in short-term

borrowings. During the three months ended March 29, 2025, the Company used $2 million of cash for debt issuance

costs related to the credit facility amendment during the three months ended March 29, 2025. During both the three

months ended March 29, 2025 and March 30, 2024, the Company repurchased $1 million of its stock in connection with

the vesting of employee restricted stock awards.

In the second quarter of fiscal 2022, the Company suspended share repurchases under its Board-approved share

repurchase program. At March 29, 2025, there was $348 million remaining authorization under the Board-approved

$600 million share repurchase program. There is no expiration date governing the period over which the Company can

repurchase shares. The Company made no share repurchases under its Board-approved share repurchase program in

either period.

At March 29, 2025, the Company had $558 million of borrowings under its revolving credit facility, $7 million in

outstanding letters of credit and net liquidity available under the credit facility of $110 million. Total availability under its

revolving credit facility was $675 million, which amortizes by $2.5 million per quarter through December 2026. At

March 29, 2025, the Company’s leverage ratio as defined in the credit agreement was 4.5x versus the permissible net

leverage ratio of 4.75x, the weighted-average interest rate on borrowings under the credit facility was 7.9% and the

Company was in compliance with all financial covenants.

### 23 \| 1Q 2025 FORM 10-Q SLEEP NUMBER CORPORATION

### Non-GAAP Data Reconciliations

#### Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)

The Company defines earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net loss plus:

income tax expense (benefit), interest expense, depreciation and amortization, stock-based compensation, restructuring

costs, CEO transition/proxy contest costs and asset impairments. Management believes Adjusted EBITDA is a useful

indicator of the Company’s financial performance and its ability to generate cash from operating activities. The

Company’s definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other

companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable

GAAP financial measure.

Adjusted EBITDA calculations are as follows (in thousands):

|  | Three Months Ended March 29, 2025 | March 30, 2024 | Trailing-Twelve Months Ended March 29, 2025 | March 30, 2024 |
| --- | ---: | ---: | ---: | ---: |
| Net loss | $(8,646) | $(7,482) | $(21,498) | $(34,234) |
| Income tax (benefit) expense | (585) | 725 | (6,472) | (9,107) |
| Interest expense | 11,081 | 12,299 | 47,150 | 45,892 |
| Depreciation and amortization | 14,406 | 17,145 | 62,240 | 71,633 |
| Stock-based compensation | 3,951 | 4,117 | 11,278 | 14,333 |
| Restructuring costs (1) | 60 | 10,600 | 7,526 | 26,328 |
| CEO transition/Proxy contest costs (2) | 1,774 | — | 2,772 | — |
| Asset impairments | — | — | 1,220 | 660 |
| Adjusted EBITDA | $22,041 | $37,404 | $104,216 | $115,505 |

(1) Represents costs related to business restructuring actions initiated in the fourth quarter of fiscal 2023.

(2) Represents costs related to CEO transition activities and proxy contest costs of $0.6 million and $1.2 million, respectively, for the three months

ended March 29, 2025 and $0.8 million and $2.0 million, respectively, for the trailing twelve months ended March 29, 2025. These costs were both

initiated in the fourth quarter of fiscal 2024.

#### Free Cash Flow

The Company’s “free cash flow” data is considered a non-GAAP financial measure and is not in accordance with, or

preferable to, “net cash provided by operating activities,” or GAAP financial data. However, the Company is providing

this information as it believes it facilitates analysis for investors and financial analysts.

The following table summarizes free cash flow calculations (in thousands):

|  | Three Months Ended March 29, 2025 | March 30, 2024 | Trailing-Twelve Months Ended March 29, 2025 | March 30, 2024 |
| --- | ---: | ---: | ---: | ---: |
| Net cash (used in) provided by operating activities | $(2,626) | $33,745 | $(9,228) | $6,136 |
| Subtract: Purchases of property and equipment | 4,599 | 9,308 | 18,796 | 50,808 |
| Free cash flow | $(7,225) | $24,437 | $(28,024) | $(44,672) |

### 24 \| 1Q 2025 FORM 10-Q SLEEP NUMBER CORPORATION

### Non-GAAP Data Reconciliations (continued)

#### Return on Invested Capital (Adjusted ROIC)

Adjusted ROIC is a financial measure the Company uses to determine how efficiently it deploys its capital. It quantifies

the return the Company earns on its adjusted invested capital. Management believes Adjusted ROIC is also a useful

metric for investors and financial analysts. The Company computes Adjusted ROIC as outlined below. Its definition and

calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other

companies.

The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested

capital, which are non-GAAP financial measures, to the comparable GAAP financial measures (in thousands):

| Adjusted net operating profit after taxes (Adjusted NOPAT) | Trailing-Twelve Months Ended March 29, 2025 | March 30, 2024 |
| --- | ---: | ---: |
| Operating income | $19,180 | $2,550 |
| Add: Operating lease expense (1) | 26,098 | 27,882 |
| Less: Income taxes (2) | (10,022) | (7,479) |
| Adjusted NOPAT | $35,256 | $22,953 |
| Average adjusted invested capital |  |  |
| Total deficit | $(456,844) | $(445,863) |
| Add: Long-term debt (3) | 557,921 | 523,800 |
| Add: Operating lease obligations (4) | 376,909 | 424,746 |
| Total adjusted invested capital at end of period | $477,986 | $502,683 |
| Average adjusted invested capital (5) | $487,361 | $505,498 |
| Adjusted return on invested capital (Adjusted ROIC) (6) | 7.2% | 4.5% |

(1) Represents the interest expense component of lease expense included in the Company’s financial statements under ASC 842, *Leases.*

(2) Reflects annual effective income tax rates, before discrete adjustments, of 22.1% and 24.6% for March 29, 2025 and March 30, 2024, respectively.

(3) Long-term debt includes existing finance lease liabilities.

(4) Reflects operating lease liabilities included in the Company’s financial statements under ASC 842.

(5) Average adjusted invested capital represents the average of the last five fiscal quarters’ ending adjusted invested capital balances.

(6) Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital.

Note - the Company’s adjusted ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable

to, GAAP financial data. However, the Company is providing this information as it believes it facilitates analysis of the Company's financial performance

by investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.

### Critical Accounting Policies

The Company discusses its critical accounting policies and estimates in *Management’s Discussion and Analysis of*

*Financial Condition and Results of Operations* in the Company’s Annual Report on Form 10-K for the fiscal year ended

December 28, 2024. There were no significant changes in the Company’s critical accounting policies since the end of

fiscal 2024.

### 25 \| 1Q 2025 FORM 10-Q SLEEP NUMBER CORPORATION

## Market risk

As filed, 475 characters.

The Company is exposed to changes in market-based short-term interest rates that will impact net interest expense. If

overall interest rates were one percentage point higher than current rates, annual net income would decrease by

$4.3 million based on the $558 million of borrowings under the credit facility at March 29, 2025. The Company does not

manage the interest-rate volatility risk of borrowings under the credit facility through the use of derivative instruments.

## Controls and procedures

As filed, 1,657 characters.

### Conclusions Regarding the Effectiveness of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), that are

designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under

the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time

periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is

accumulated and communicated to the Company’s management, including its principal executive officer and principal

financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required

disclosure. The Company’s management, with the participation of its principal executive officer and principal financial

officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as

of the end of the period covered by this quarterly report. Based on this evaluation, its principal executive officer and

principal financial officer concluded that the Company’s disclosure controls and procedures were effective as of the end

of the period covered by this quarterly report.

### Changes in Internal Control

There were no changes in the Company’s internal control over financial reporting during the fiscal quarter ended

March 29, 2025, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control

over financial reporting.

### 26 \| 1Q 2025 FORM 10-Q SLEEP NUMBER CORPORATION

## Risk factors

As filed, 1,003 characters.

The Company’s business, financial condition and operating results are subject to a number of risks and uncertainties,

including both those that are specific to the Company’s business and others that affect all businesses operating in a

global environment. Investors should carefully consider the information in this report under the heading, *Management’s*

*Discussion and Analysis of Financial Condition and Results of Operations*, and also the information under the heading,

*Risk Factors*, in the Company’s most recent Annual Report on Form 10-K and in subsequent Quarterly Reports on

Form 10-Q. The risk factors discussed in the Annual Report on Form 10-K and in subsequent Quarterly Reports on Form

10-Q including this Quarterly Report on Form 10-Q do not identify all risks that the Company faces because its business

operations could also be affected by additional risk factors that are not presently known to the Company or that it

currently considers to be immaterial to its operations.

Filed May 6, 2025.
Source: SEC EDGAR, the filing index for accession 0000827187-25-000058. Last ingested by Listed: Oct 24, 2026, 14:57 ET. No prices; not investment advice.
